Wendell David Associates Inc Eli Lilly & CO Transaction History

Wendell David Associates Inc

$981 Million
Q2 2024

A detailed history of Wendell David Associates Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Wendell David Associates Inc holds 43,369 shares of LLY stock, worth $38.1 Million. This represents 4.0% of its overall portfolio holdings.

Number of Shares

43,369

Previous 43,564 0.45%

Holding current value

$38.1 Million

Previous $33.9 Million 15.86%

% of portfolio

4.0%

Previous 3.42%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$724.87 - $909.04 $141,349 - $177,262	-195 Reduced 0.45%	43,369 $39.3 Million
Q1 2024 Apr 22, 2024	BUY	$592.2 - $792.28 $29,610 - $39,614	50 Added 0.11%	43,564 $33.9 Million
Q4 2023 Jan 22, 2024	BUY	$525.19 - $619.13 $133,398 - $157,259	254 Added 0.59%	43,514 $25.4 Million
Q3 2023 Oct 20, 2023	BUY	$434.7 - $599.3 $414,703 - $571,732	954 Added 2.25%	43,260 $23.2 Million
Q2 2023 Jul 20, 2023	BUY	$350.74 - $468.98 $776,889 - $1.04 Million	2,215 Added 5.52%	42,306 $19.8 Million
Q2 2022 Jul 14, 2022	SELL	$278.73 - $327.27 $9,755 - $11,454	-35 Reduced 0.09%	40,091 $13 Million
Q1 2022 Apr 22, 2022	SELL	$234.69 - $291.66 $28,162 - $34,999	-120 Reduced 0.3%	40,126 $11.5 Million
Q4 2021 Jan 24, 2022	SELL	$224.85 - $279.04 $26,982 - $33,484	-120 Reduced 0.3%	40,246 $11.1 Million
Q3 2021 Oct 19, 2021	BUY	$221.6 - $272.71 $121,880 - $149,990	550 Added 1.38%	40,366 $9.33 Million
Q2 2021 Jul 19, 2021	SELL	$180.55 - $233.54 $101,108 - $130,782	-560 Reduced 1.39%	39,816 $9.14 Million
Q1 2021 Apr 20, 2021	BUY	$164.32 - $212.72 $43,873 - $56,796	267 Added 0.67%	40,376 $7.54 Million
Q4 2020 Jan 22, 2021	BUY	$130.46 - $172.63 $7,305 - $9,667	56 Added 0.14%	40,109 $6.77 Million
Q3 2019 Oct 22, 2019	SELL	$106.79 - $116.16 $21,358 - $23,232	-200 Reduced 0.5%	40,053 $4.48 Million
Q1 2019 Apr 11, 2019	BUY	$111.31 - $131.02 $4,007 - $4,716	36 Added 0.09%	40,253 $5.22 Million
Q4 2018 Jan 17, 2019	SELL	$105.9 - $118.64 $33,464 - $37,490	-316 Reduced 0.78%	40,217 $4.65 Million
Q2 2018 Jul 16, 2018	BUY	$75.7 - $86.88 $123,769 - $142,048	1,635 Added 4.2%	40,533 $3.46 Million
Q1 2018 Apr 11, 2018	BUY	$74.21 - $87.6 $12,318 - $14,541	166 Added 0.43%	38,898 $3.01 Million
Q4 2017 Jan 16, 2018	SELL	$81.94 - $87.89 $131,104 - $140,624	-1,600 Reduced 3.97%	38,732 $3.27 Million
Q3 2017 Oct 17, 2017	BUY	$77.07 - $85.54 $3.11 Million - $3.45 Million	40,332	40,332 $3.45 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.

Account

Wendell David Associates Inc Eli Lilly & CO Transaction History